Should all patients with sepsis receive anticoagulation? Yes

被引：26
作者：
Meziani, Ferhat [1 ,2 ]
Gando, Satoshi [3 ]
Vincent, Jean-Louis [4 ]
机构：
[1] Hop Univ Strasbourg, Serv Reanimat Med, Nouvel Hop Civil, 1 Pl Hop, F-67091 Strasbourg, France
[2] Univ Strasbourg, Fac Med, EA 7293, FMTS, Strasbourg, France
[3] Hokkaido Univ, Div Acute & Crit Care Med, Dept Anesthesiol & Crit Care Med, Grad Sch Med, Sapporo, Hokkaido, Japan
[4] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium
来源：
INTENSIVE CARE MEDICINE | 2017年 / 43卷 / 03期
关键词：
DISSEMINATED INTRAVASCULAR COAGULATION; HUMAN SOLUBLE THROMBOMODULIN; DIAGNOSTIC-CRITERIA; EFFICACY; SAFETY; ANTITHROMBIN; INHIBITOR; THERAPY;
D O I：
10.1007/s00134-016-4621-z
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：452 / 454
页数：3
相关论文
共 17 条
  • [1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial
    Abraham, E
    Reinhart, K
    Opal, S
    Demeyer, I
    Doig, C
    Rodriguez, AL
    Beale, R
    Svoboda, P
    Laterre, PF
    Simon, S
    Light, B
    Spapen, H
    Stone, J
    Seibert, A
    Peckelsen, C
    De Deyne, C
    Postier, R
    Pettilä, V
    Sprung, CL
    Artigas, A
    Percell, SR
    Shu, V
    Zwingelstein, C
    Tobias, J
    Poole, L
    Stolzenbach, JC
    Creasey, AA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02): : 238 - 247
  • [2] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [3] Early Detection of Disseminated Intravascular Coagulation During Septic Shock: A Multicenter Prospective Study
    Delabranche, Xavier
    Quenot, Jean-Pierre
    Lavigne, Thierry
    Mercier, Emmanuelle
    Francois, Bruno
    Severac, Francois
    Grunebaum, Lelia
    Mehdi, Madah
    Zobairi, Fatiha
    Toti, Florence
    Meziani, Ferhat
    Boisrame-Helms, Julie
    [J]. CRITICAL CARE MEDICINE, 2016, 44 (10) : E930 - E939
  • [4] DELLINGER RP, 2013, INTENS CARE MED, V39, P165, DOI DOI 10.1007/s00134-012-2769-8
  • [5] Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation
    Dhainaut, JF
    Yan, SB
    Joyce, DE
    Pettilä, V
    Basson, B
    Brandt, JT
    Sundin, DP
    Levi, M
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) : 1924 - 1933
  • [6] Thrombosis as an intravascular effector of innate immunity
    Engelmann, Bernd
    Massberg, Steffen
    [J]. NATURE REVIEWS IMMUNOLOGY, 2013, 13 (01) : 34 - 45
  • [7] COAGULATION INHIBITOR SUBSTITUTION DURING SEPSIS
    FOURRIER, F
    JOURDAIN, M
    TOURNOIS, A
    CARON, C
    GOUDEMAND, J
    CHOPIN, C
    [J]. INTENSIVE CARE MEDICINE, 1995, 21 : S264 - S268
  • [8] Severe sepsis, coagulation, and fibrinolysis: Dead end or one way?
    Fourrier, Francois
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (09) : 2704 - 2708
  • [9] What's new in the diagnostic criteria of disseminated intravascular coagulation?
    Gando, Satoshi
    Meziani, Ferhat
    Levi, Marcel
    [J]. INTENSIVE CARE MEDICINE, 2016, 42 (06) : 1062 - 1064
  • [10] A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis
    Gando, Satoshi
    Saitoh, Daizoh
    Ishikura, Hiroyasu
    Ueyama, Masashi
    Otomo, Yasuhiro
    Oda, Shigeto
    Kushimoto, Shigeki
    Tanjoh, Katsuhisa
    Mayumi, Toshihiko
    Ikeda, Toshiaki
    Iba, Toshiaki
    Eguchi, Yutaka
    Okamoto, Kohji
    Ogura, Hiroshi
    Koseki, Kazuhide
    Sakamoto, Yuichiro
    Takayama, Yasuhiro
    Shirai, Kunihiro
    Takasu, Osamu
    Inoue, Yoshiaki
    Mashiko, Kunihiro
    Tsubota, Takaya
    Endo, Shigeatsu
    [J]. CRITICAL CARE, 2013, 17 (06):
12